Teaching hospital Program year 2025 Source: CMS Open Payments

Emory University Hospital

GA

CCN 110010 CMS hospital 15967

Open in the dashboard

General payments

$51,929,849

2,943 payments

Research payments

$311,131,757

24,406 payments

Through program year 2025, Emory University Hospital is reported as receiving $51,929,849 in general payments and $311,131,757 in research payments from drug and medical device manufacturers.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

14 rows
Year Kind Amount Payments
2025 General $7,168,281 357
2025 Research $51,317,877 4,793
2024 General $8,885,952 308
2024 Research $41,601,365 3,829
2023 General $6,795,483 373
2023 Research $48,514,741 2,967
2022 General $7,003,836 430
2022 Research $44,910,953 3,294
2021 General $6,204,309 341
2021 Research $41,371,551 3,001
2020 General $7,862,363 380
2020 Research $45,524,557 3,450
2019 General $8,009,626 754
2019 Research $37,890,712 3,072

Breakdown

Who paid General payments · program years 2019–2025
  1. Gilead Sciences, Inc. $19,303,552 63 payments
  2. Takeda Pharmaceuticals U.S.A., Inc. $10,366,630 47 payments
  3. Shire North American Group Inc $2,234,825 16 payments
  4. Edwards Lifesciences Corporation $1,347,994 65 payments
  5. Pfizer Inc. $1,250,557 53 payments
  6. Abbott Laboratories $1,200,400 77 payments
  7. Siemens Medical Solutions USA, Inc. $1,009,817 138 payments
  8. KARL STORZ Endoscopy-America $898,688 734 payments
  9. Genentech, Inc. $825,500 7 payments
  10. Medical Device Business Services, Inc. $757,159 33 payments
  11. Other $12,734,728 1,710 payments
What the payments were for General payments · program years 2019–2025
  1. Grant $28,870,140 515 payments
  2. Royalty or License $13,987,186 468 payments
  3. Space rental or facility fees (teaching hospital only) $2,977,807 662 payments
  4. Education $2,132,777 557 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,919,224 116 payments
  6. Consulting Fee $847,409 79 payments
  7. Charitable Contribution $787,172 73 payments
  8. Long term medical supply or device loan $155,162 56 payments
  9. Gift $141,307 267 payments
  10. Honoraria $62,900 7 payments
  11. Other $48,767 143 payments
Products named General payments · program years 2019–2025
  1. Obizur $11,678,792 26 payments
  2. Neurostar TMS Therapy $650,477 8 payments
  3. Kengreal $368,012 1 payment
  4. Edwards Sapien 3 Transcatheter Heart Valve (THV) $257,400 24 payments
  5. I-Stat $200,000 1 payment
  6. Lumason $170,000 2 payments
  7. Oxbryta $169,036 1 payment
  8. Resolute $156,144 3 payments
  9. General Vascular Intervention $148,800 1 payment
  10. JenaValve Pericardial TAVR System $145,473 5 payments
  11. Other $6,546,432 1,735 payments

A payment can name more than one product, so these amounts overlap.

2,943 general · 24,406 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

A teaching hospital's total is institutional. It is money reported as going to the hospital itself, and it is kept separate from anything reported about the individual clinicians who work there — the two are never added together.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record